Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analgesic, antihistamine, anthelmintic, anti-malarial, antibacterial, vitamins, antifungal, diuretics, oxytocic, antacid, laxative, anticoagulant, anaesthetic, bronchodilator, adrenergic, sedative, anti-inflammatory, antiemetic, anticonvulsant, antipsychotic, antidepressant, and anti-cancer. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Metrics to compare | SAKA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSAKAPeersSector | |
---|---|---|---|---|
P/E Ratio | 38.2x | 26.7x | −0.7x | |
PEG Ratio | 0.57 | 0.54 | 0.00 | |
Price/Book | 2.6x | 3.9x | 2.6x | |
Price / LTM Sales | 4.0x | 3.1x | 3.4x | |
Upside (Analyst Target) | - | 19.9% | 35.7% | |
Fair Value Upside | Unlock | 0.4% | 4.1% | Unlock |